ENSG vs INSM: fair value comparison
The Ensign Group, Inc. and Insmed Incorporated · Updated 2026-10-19
INSM's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Healthcare, ENSG currently ranks higher by quality score.
| ENSG | INSM | |
|---|---|---|
| Verdict | Fairly valued | Awaiting full valuation |
| Last price | $176.63 | $96.27 |
| 12-month range | $147.13–$215.83 | $91.88–$211.41 |
| Rank by discount to fair value | #44 of 108 Healthcare | — |
| Rank by quality score | #134 of 301 Healthcare | #135 of 301 Healthcare |
| Quality grade | D | D |
| Leverage | Moderate | Moderate |
| Margin trend | Contracting | Expanding |
| Revenue growth | Strong | High |
| RSI zone | Neutral | Oversold |
| 50/200-day trend | Mixed | Downtrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The lower-middle quarter | The bottom quarter |
Full single-stock breakdowns: ENSG fair value analysis · INSM fair value analysis